ACADIA Pharmaceuticals Inc to Host Investor Event and Webcast From Clinical Trials on Alzheimer's Disease (CTAD) Meeting Transcript
All right. Good evening, everyone. I think we're ready to start. Thank you for joining us tonight to discuss the top line results from the Phase III HARMONY study in dementia-related psychosis, or DRP. I'd like to point out that we are using supplemental slides, which are available on the Events & Presentations section of our IR website.
First, tonight, we will hear from Steve Davis, our Chief Executive Officer, who will provide a few opening remarks; and then turn it over to Erin Foff, the clinical lead for our DRP program, who just presented at the 12th Annual Clinical Trials of Alzheimer's Disease Meeting these exciting results. Following Erin's presentation, Serge Stankovic, our President, will make a few remarks on our next steps for DRP. And then we will transition to a KOL panel to discuss with a Q&A.
I'm extremely pleased to introduce our 3 panelists this evening: Dr. Jeff Cummings, a research professor from the Department of Brain Health at UNLV and Director Emeritus at the Cleveland Clinic Lou Ruvo Center for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
